Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HiCM-188 in severe chronic ischemic heart failure
NCT06340048Phase 2Active, not recruiting
- Sponsor
- Help Therapeutics
- Start
- Sep 2023
- Primary completion
- Nov 2026
- Modality
- Patient-derived iPSCs, Allogeneic iPSCs
- Countries
- 1
01
Overview
A Phase 2 trial of HiCM-188 in Ischemic Heart Failure (IHF), sponsored by Help Therapeutics. Started Sep 2023; status: active, not recruiting.
02
Drugs
HiCM-188
03
Conditions
Ischemic Heart Failure (IHF)
Beyond the preview
Go deeper on NCT06340048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06340048.